Cite
HARVARD Citation
Cusan, M. et al. (2022). NEK2, a promising target in TP53 mutant cancer. Blood science. 4 (2), pp. 97-98. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cusan, M. et al. (2022). NEK2, a promising target in TP53 mutant cancer. Blood science. 4 (2), pp. 97-98. [Online].